Investing Profile

Karl Handelsman(204)

CEO

Founder & Investor at Codon Capital

Your Intro Paths to Karl Handelsman

Signal uses Gmail to reveal intro paths. Email content is never read.

Karl Handelsman's investing connections

Connected to 9 investors on Signal.

Networks Karl is a member of

Stanford University Network

364 CONNECTIONS

Genentech Network

69 CONNECTIONS

UCSF Network

14 CONNECTIONS

UCSF Network

14 CONNECTIONS

Find Karl Handelsman on

Current Investing Position

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Karl Handelsman is on these Sector & Stage Rankings

Karl Handelsman's Investments On Record (3)

Company	StageDateRound Size	Total Raised
Bonum Therapeutics	Series ANov 2022$93M	$93M
Co-investors: John McKearn (RiverVest Venture Partners), Samuel Bjork (Digitalis Ventures), Monique Schiersing (Roche Venture Fund)
Good Therapeutics	Series AFeb 2019$11M	$30M
Co-investors: John McKearn (RiverVest Venture Partners), Samuel Bjork (Digitalis Ventures), Monique Schiersing (Roche Venture Fund)
Clear Labs	Series BOct 2018$21M	$170M
Co-investors: Aydin Senkut (Felicis Ventures), Krishna Yeshwant (GV (Google Ventures)), Greg Yap (Menlo Ventures), Chris Sklarin (Castor Ventures), Miguel Valls (Alta Life Sciences), Kyle Kurpinski (Tencent Holdings)

Karl Handelsman's Experience

Member Life Science Angels2014 - Present

Catalyst Advisory Panel UCSF2013 - Present

SPARK Selection Committee Stanford University2013 - Present

Founder & Investor Codon Capital2013 - Present

Senior Advisor, Roche Venture Fund Genentech2016 - 2021

Mentor California Inst. for Regenerative Medicine2013 - 2016

Lean Launchpad for Therapeutics/Tools Instructor UCSF2013 - 2016

General Partner Emeritus CMEA Capital2013 - 2014

Managing Director/General Partner CMEA Capital1999 - 2013

Director, Business Development Millennium Pharmaceuticals1996 - 1997

Manager, Business Development Tularik1992 - 1996

Investors who invest with Karl Handelsman

Scouts & Angels Affiliated With Karl Handelsman